Orlando Oliveira is a Portuguese executive with over 25 years of international experience in the pharmaceutical and biotechnology industries. He currently serves as Chief Commercial Officer at Zenas BioPharma (Boston) and sits on the Board of Directors of OncoInvent (Norway).

Throughout his career, he has led global operations at renowned companies such as Mirati Therapeutics, TESARO, Agios, Cubist, and AMGEN, contributing to four successful exits of biotech startups.

He holds a degree in Pharmacy from the University of Coimbra and has completed executive education programs at the Harvard Business School and INSEAD. His areas of expertise include oncology, rare diseases, biosimilars, and market access strategy.

Having lived and worked in five countries, he is fluent in four languages. He has been recognized as an “Emerging Leader” by the Harvard Club of Portugal and as a “Greater Zurich Honorary Ambassador.”

Orlando Oliveira has been Portugal’s World Advisor since June 2025.